Abstract
This study compares the results of modified radical mastectomy (144 cases) to radical mastectomy (188 cases) in the treatment of operable breast cancer. 205 patients had Stage I breast cancer, 60 had Stage II disease and 67 had Stage III disease (TNM System). There was no statistically significant difference in 5 yr survival when the results of a radical mastectomy were compared to a modified radical mastectomy at any stage of disease. There was no statistically significant difference in the incidence of local recurrence in patients with Stage I and Stage II disease when the results of a radical mastectomy were compared to modified radical mastectomy. Those patients with Stage III disease who were treated by a modified radical mastectomy had a statistically significant higher incidence of local recurrence (chest wall and axilla) in comparison to patients treated by radical mastectomy. We have concluded that a modified radical mastectomy is the treatment of choice in patients with Stage I and Stage II diseases. In patients with Stage III disease a radical mastectomy provides a better chance of local control of the disease but offers no increased chance of survival.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 553-559 |
| Number of pages | 7 |
| Journal | Annals of Surgery |
| Volume | 189 |
| Issue number | 5 |
| State | Published - 1979 |
Fingerprint
ASJC Scopus subject areas
- Surgery
Cite this
A comparison of modified radical mastectomy to radical mastectomy in the treatment of operable breast cancer. / Baker, R. Robinson; Montague, A. C W; Childs, J. N.
In: Annals of Surgery, Vol. 189, No. 5, 1979, p. 553-559.Research output: Contribution to journal › Article
}
TY - JOUR
T1 - A comparison of modified radical mastectomy to radical mastectomy in the treatment of operable breast cancer
AU - Baker, R. Robinson
AU - Montague, A. C W
AU - Childs, J. N.
PY - 1979
Y1 - 1979
N2 - This study compares the results of modified radical mastectomy (144 cases) to radical mastectomy (188 cases) in the treatment of operable breast cancer. 205 patients had Stage I breast cancer, 60 had Stage II disease and 67 had Stage III disease (TNM System). There was no statistically significant difference in 5 yr survival when the results of a radical mastectomy were compared to a modified radical mastectomy at any stage of disease. There was no statistically significant difference in the incidence of local recurrence in patients with Stage I and Stage II disease when the results of a radical mastectomy were compared to modified radical mastectomy. Those patients with Stage III disease who were treated by a modified radical mastectomy had a statistically significant higher incidence of local recurrence (chest wall and axilla) in comparison to patients treated by radical mastectomy. We have concluded that a modified radical mastectomy is the treatment of choice in patients with Stage I and Stage II diseases. In patients with Stage III disease a radical mastectomy provides a better chance of local control of the disease but offers no increased chance of survival.
AB - This study compares the results of modified radical mastectomy (144 cases) to radical mastectomy (188 cases) in the treatment of operable breast cancer. 205 patients had Stage I breast cancer, 60 had Stage II disease and 67 had Stage III disease (TNM System). There was no statistically significant difference in 5 yr survival when the results of a radical mastectomy were compared to a modified radical mastectomy at any stage of disease. There was no statistically significant difference in the incidence of local recurrence in patients with Stage I and Stage II disease when the results of a radical mastectomy were compared to modified radical mastectomy. Those patients with Stage III disease who were treated by a modified radical mastectomy had a statistically significant higher incidence of local recurrence (chest wall and axilla) in comparison to patients treated by radical mastectomy. We have concluded that a modified radical mastectomy is the treatment of choice in patients with Stage I and Stage II diseases. In patients with Stage III disease a radical mastectomy provides a better chance of local control of the disease but offers no increased chance of survival.
UR - http://www.scopus.com/inward/record.url?scp=0018764244&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0018764244&partnerID=8YFLogxK
M3 - Article
C2 - 443908
AN - SCOPUS:0018764244
VL - 189
SP - 553
EP - 559
JO - Annals of Surgery
JF - Annals of Surgery
SN - 0003-4932
IS - 5
ER -